Published :
Tables : 120
Figures : 25
Category : Healthcare
No. of Pages : 200
Report Code : HC-1194
Medical Simulation Market Introduction Medical Simulation Market is estimated to value over USD 6.27 billion by 2027 end and register a CAGR of over 13.9% during the forecast period 2020 to 2027. The medical simulation market growth is encouraged by factors like enlightening the medical fraternity about the evolution of medical technology, associated benefits of medical simulation and a growing emphasis on patient safety and outcome such as illustrating normal and complex cases to professionals. Nonetheless, high simulation set-up cost and other related costs are predicted to restrain the market growth of the market. Additionally, the limitation of a complete real situation impedes the growth of the medical simulation industry. On the contrary, profitable opportunities in emerging economies are predicted to create opportunities for market growth soon. Furthermore, according to an article published by NCBI, more than 200,000 patients die annually owing to medical errors, which makes it the third leading cause of death in the world. The invention of simulation in healthcare has significantly reduced the number of deaths related to unsafe care. These factors are expected to boost the market growth in the upcoming years. Key market players include Cae, 3D Systems, Laerdal Medical, Gaumard Scientific Company, Kyoto Kagaku, Limbs & Things, Mentice, Simulab, Simulaids, Medaphor. Medical Simulation Market Segmentation: By Product & Service Anatomical Models Patient Simulators High-Fidelity Simulators Medium-Fidelity Simulators Low-Fidelity Simulators Task Trainers Interventional/Surgical Simulators Laparoscopic Surgical Simulators Gynecology Surgical Simulators Cardiac Surgical Simulators Arthroscopic Surgical Simulators Other Interventional/Surgical Simulators Endovascular Simulators Ultrasound Simulators Dental Simulators Eye Simulators Web-Based Simulation Medical Simulation Software Performance Recording Software Virtual Tutors Simulation Training Services Vendor-Based Training Educational Societies Custom Consulting & Training Services By End User Academic Institutes Hospitals Military Organizations Other End Users By Region North America Europe Asia Pacific Latin America Middle East & Africa FutureWise Key Takeaways: Growth Prospects SWOT Analysis Key Trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global medical simulation market by product & service, by end-user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) Evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and Middle East & Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financial and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Medical Simulation Market is estimated to value over USD 6.27 billion by 2027 end and register a CAGR of over 13.9% during the forecast period 2020 to 2027.
The medical simulation market growth is encouraged by factors like enlightening the medical fraternity about the evolution of medical technology, associated benefits of medical simulation and a growing emphasis on patient safety and outcome such as illustrating normal and complex cases to professionals.
Nonetheless, high simulation set-up cost and other related costs are predicted to restrain the market growth of the market. Additionally, the limitation of a complete real situation impedes the growth of the medical simulation industry. On the contrary, profitable opportunities in emerging economies are predicted to create opportunities for market growth soon. Furthermore, according to an article published by NCBI, more than 200,000 patients die annually owing to medical errors, which makes it the third leading cause of death in the world. The invention of simulation in healthcare has significantly reduced the number of deaths related to unsafe care. These factors are expected to boost the market growth in the upcoming years.
Key market players include Cae, 3D Systems, Laerdal Medical, Gaumard Scientific Company, Kyoto Kagaku, Limbs & Things, Mentice, Simulab, Simulaids, Medaphor.
Medical Simulation Market Segmentation:
By Product & Service
By End User
By Region
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Medical Simulation Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Medical Simulation Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Medical Simulation Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Medical Simulation Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Medical Simulation Market, By Product & Service Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Anatomical Models 7.1.2. Patient Simulators 7.1.2.1. High-Fidelity Simulators 7.1.2.2. Medium-Fidelity Simulators 7.1.2.3. Low-Fidelity Simulators 7.1.3. Task Trainers 7.1.4. Interventional/Surgical Simulators 7.1.4.1. Laparoscopic Surgical Simulators 7.1.4.2. Gynecology Surgical Simulators 7.1.4.3. Cardiac Surgical Simulators 7.1.4.4. Arthroscopic Surgical Simulators 7.1.4.5. Other Interventional/Surgical Simulators 7.1.5.Endovascular Simulators 7.1.6.Ultrasound Simulators 7.1.7 Dental Simulators 7.1.8 Eye Simulators 7.2. Web-Based Simulation 7.3. Medical Simulation Software 7.3.1. Performance Recording Software 7.3.2. Virtual Tutors 7.4. Simulation T3aining Services 7.4.1. Vendor-Based Training 7.4.2. Educational Societies 7.4.3. Custom Consulting & Training Services 8. Global Medical Simulation Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Academic Institutes 8.2. Hospitals 8.3. Military Organizations 8.4. Other End Users 9. North America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2020-2027 10. Latin America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 10.2.1. Brazil 10.2.2. Venezuela 10.2.3. Argentina 10.2.4. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2020-2027 11. Europe Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2020-2027 12. Asia Pacific Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Saudi Arabia 13.2.2. UAE 13.2.3. South Africa 13.2.4. Egypt 13.3. Market Size (USD Million) Forecast for MEA 2020-2027 14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 14.1. Cae 14.1.1. Company Overview 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2. 3D Systems 14.2.1. Company Overview 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3. Laerdal Medical 14.3.1. Company Overview 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4. Gaumard Scientific Company 14.4.1. Company Overview 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5 3M Kyoto Kagaku 14.5.1. Company Overview 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 14.6 Limbs & Things 14.6.1. Company Overview 14.6.2. Product Portfolio 14.6.3. SWOT Analysis 14.6.4. Financial Overview 14.6.5. Strategic Overview 14.7. Mentice 14.7.1. Company Overview 14.7.2. Product Portfolio 14.7.3. SWOT Analysis 14.7.4. Financial Overview 14.7.5. Strategic Overview 14.8. Simulab 14.8.1. Company Overview 14.8.2. Product Portfolio 14.8.3. SWOT Analysis 14.8.4. Financial Overview 14.8.5. Strategic Overview 14.9. Simulaids. 14.9.1. Company Overview 14.9.2. Product Portfolio 14.9.3. SWOT Analysis 14.9.4. Financial Overview 14.9.5. Strategic Overview 14.10. Medaphor 14.10.1. Company Overview 14.10.2. Product Portfolio 14.10.3. SWOT Analysis 14.10.4. Financial Overview 14.10.5. Strategic Overview 15. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics